About TORIPALIMAB
            
            Class: | Monoclonal Antibody; PD-1 Inhibitor  
Use: | Toripalimab is used for the treatment of various cancers, including melanoma, nasopharyngeal carcinoma, and other solid tumors, often in cases where other treatments have failed or are not suitable.  
Adult dose: | The standard adult dosing for Toripalimab is 240 mg administered intravenously every 2 weeks.  
Pediatric dose: | Pediatric dosing has not been established; use in children should be guided by clinical trials or specialist advice. 
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal Antibody; PD-1 Inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Toripalimab is used for the treatment of various cancers, including melanoma, nasopharyngeal carcinoma, and other solid tumors, often in cases where other treatments have failed or are not suitable.
                 
                
                
                    
                        Storage Requirements
                    
                    Store Toripalimab vials in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep in the original packaging until use.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Al Hikma Pharmaceuticals, JORDAN
                    
                    
                    Package Size
                    1's - 6ml
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 24079.80
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        The standard adult dosing for Toripalimab is 240 mg administered intravenously every 2 weeks.
                    
                    
                        Pediatric Dose
                    
                    
                        Pediatric dosing has not been established; use in children should be guided by clinical trials or specialist advice.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include fatigue, rash, pruritus, diarrhea, nausea, and infusion-related reactions.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindications include known hypersensitivity to Toripalimab or any of its components. Caution is advised in patients with autoimmune diseases or those receiving immunosuppressive therapy.
         
        
        
            
                Important Warnings
            
            Important safety warnings include the risk of immune-mediated adverse reactions, such as pneumonitis, hepatitis, colitis, endocrinopathies, and nephritis. Monitor patients closely for signs and symptoms of these conditions and manage promptly with corticosteroids or other appropriate measures.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.